首页> 外文期刊>European journal of human genetics: EJHG >Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome
【24h】

Targeted deep-intronic sequencing in a cohort of unexplained cases of suspected Lynch syndrome

机译:针对无疑的局部局部综合征的未解释的病例队列中的深入内含性测序

获取原文
获取原文并翻译 | 示例
       

摘要

Lynch syndrome (LS) is caused by germline defects in DNA mismatch repair (MMR) pathway, resulting in microsatellite instability (MSI-H) and loss of immunohistochemical staining (IHC) of the respective protein in tumor tissue. However, not in all clinically suspected LS patients with MSI-H tumors and IHC-loss, causative germline alterations in the MMR genes can be detected. Here, we investigated 128 of these patients to possibly define new pathomechanisms. A search for large genomic rearrangements and deep-intronic regulatory variants was performed via targeted next-generation sequencing (NGS) of exonic, intronic, and chromosomal regions upstream and downstream of MLH1, MSH2, MSH6, PMS2, MLH3, MSH3, PMS1, and EPCAM. Within this cohort, two different large rearrangements causative for LS were detected in three cases, belonging to two families (2.3%). The sensitivity to detect large rearrangements or copy number variations (CNV) was evaluated to be 50%. In 9 of the 128 patients (7%), previously overlooked pathogenic single-nucleotide variants (SNV) and two variants of uncertain significance (VUS) were identified in MLH1, MSH2, and MSH6. Pathogenic aberrations were not found in MLH3, MSH3, and PMS1. A potential effect on regulation was exerted for 19% of deep-intronic SNVs, predominantly located in chromosomal regions where the modification of histone proteins suggests an enhancer function. In conclusion, conventional variation analysis of coding regions is missing rare genomic rearrangements, nevertheless they should be analyzed. Assessment of deep-intronic SNVs is so far non-conclusive for medical questioning.
机译:Lynch综合征(LS)是由DNA失配修复(MMR)途径的种系缺陷引起的,导致微卫星不稳定性(MSI-H)和肿瘤组织中各种蛋白质的免疫组织化学染色(IHC)的丧失。然而,在所有临床疑似的LS患者和IHC损失中,可以检测MMR基因的致病种系改变。在这里,我们调查了这些患者中的128名患者可能定义了新的土地机制。通过MLH1,MSH2,MSH6,PMS2,MLH3,MSH3,PMS1和下游的偏振,内部和染色体区域的靶向下一代测序(NGS)进行大型基因组重排和深入内肠道调节变体进行深入基因组重排和深入监管变体。 EPCAM。在这种队列中,在三种情况下检测到LS的两个不同的大重排,属于两个家庭(2.3%)。检测大重排或拷贝数变异(CNV)的敏感性评估为50%。在128名患者(7%)的9例中,在MLH1,MSH2和MSH6中鉴定出先前被忽视的致病单核苷酸变体(SNV)和两个不确定意义(VUS)的两个变体。在MLH3,MSH3和PMS1中未发现致病畸变。施加对调节的潜在影响是19%的深入内肠SNV,主要位于组蛋白的改性的染色体区域中,提高了增强剂功能。总之,编码区的常规变异分析缺少罕见的基因组重排,然而应分析它们。深入内肠SNV的评估是远远不确定的医疗质疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号